Retatrutide: The Triple-Threat Obesity Drug Redefining Weight Loss Medicine
Leading the charge is retatrutide, a next-generation obesity drug developed by Eli Lilly that’s generating unprecedented excitement. Dubbed the “triple agonist,”…
Sitting is the New Smoking: Why Your Chair Might Be Killing You
For decades, smoking was branded as the ultimate health villain. Today, researchers warn that “sitting is the new smoking”—a silent killer…
Weight Loss Market Outlook 2030: Growth Drivers & Key Segments
The $1.5 Trillion Weight Loss Economy of 2030: A Breakdown of the Market Reshaping Health By 2030, the global weight…
PM Modi’s Anti-Obesity Drive and India’s Obesity Challenge: Key Note
1. PM Modi’s Anti-Obesity Campaign 2. India’s Obesity Challenge 3. Health Risks of Obesity 4. Why the Definition of Obesity…
Next Up in Obesity Drugs: A Timeline of What’s Coming to Market (2026–2028+)
The fight against obesity is entering an exciting new era. With blockbuster drugs like Wegovy (semaglutide) and Zepbound (tirzepatide) already…
Myostatin’s Role in the Next Weight-Loss Revolution
Key Points Background Current weight-loss methods, including lifestyle changes, surgery, and drugs like Wegovy and Zepbound, often result in both…
Foods to Reduce Obesity
Incorporating these nutrient-dense, metabolism-boosting foods into your diet can support weight loss and improve overall health. 1. Leafy Greens (Spinach,…